Stock UDJ APPLIED DNA SCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Applied DNA Sciences, Inc. BOERSE MUENCHEN

Equities

UDJ

US03815U4094

Real-time BOERSE MUENCHEN
Other stock markets
 03:44:00 2024-07-16 pm EDT 		5-day change 1st Jan Change
0.404 EUR 0.00% Intraday chart for Applied DNA Sciences, Inc. +5.76% -96.57%
Jun. 20 Applied DNA Sciences, Inc. and Alphazyme LLC Conclude Linea (TM) RNAP Manufacturing Scale-Up Project, Deliver Substantial Improvement in Linea (TM) IVT Platform Economics CI
Jun. 18 Applied DNA Partners With GenXys For Pharmacogenetic Testing MT

Other languages

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Applied DNA Sciences, Inc. and Alphazyme LLC Conclude Linea (TM) RNAP Manufacturing Scale-Up Project, Deliver Substantial Improvement in Linea (TM) IVT Platform Economics
Applied DNA Partners With GenXys For Pharmacogenetic Testing
Applied DNA Sciences, Inc. Receives Approval for TR8(TM) Pharmacogenomic Testing Service from New York State Department of Health
Applied DNA Sciences May Seek Potential Acquisitions
Top Midday Decliners
Applied DNA Sciences Prices $12 Million Public Offering of Units
Top Premarket Decliners
Applied DNA Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024
Applied DNA Sciences Regains Nasdaq Minimum Bid Price Requirement
Banned Chinese cotton found in 19% of US retailers' merchandise, study shows
Applied DNA Sciences, Inc. Receives Contract by HDT Bio for Rapid Vaccine Development Program
Applied DNA Sciences, Inc. to Showcase Linea DNA and Linea IVT Platforms At 24Th Annual World Vaccine Congress
Applied DNA Sciences Files Prospectus for Potential Secondary Stock Offerings
Applied DNA Sciences, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023
Applied DNA Sciences, Inc. Announces Joint Development Agreement to Integrate Linea IVT Platform into CDMO Kudo Biotechnology?s mRNA Manufacturing Workflow
Applied DNA Sciences, Inc. Reports Earnings Results for the Fourth Quarter Ended September 30, 2023
Applied DNA Sciences, Inc. Reports Earnings Results for the Full Year Ended September 30, 2023
Applied DNA Sciences, Inc. Announces Receipt of Linea(TM) DNA Follow-On Order for Cancer Diagnostic Application
Applied DNA Sciences, Inc. Extends Application of Linea(Tm) Ivt Platform to Sna (Self-Amplifying Mrna)
Applied DNA Sciences, Inc. Advances Commercialization of Linea(TM) IVT Platform
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. APDN Stock
  4. UDJ Stock
  5. News Applied DNA Sciences, Inc.
  6. Other languages